Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School

Last Updated: December 13, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Denufosol

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What is the drug development status for Denufosol?

Denufosol is an investigational drug.

There have been 15 clinical trials for Denufosol. The most recent clinical trial was a Phase 3 trial, which was initiated on July 1st 2006.

The most common disease conditions in clinical trials are Fibrosis, Cystic Fibrosis, and Lung Diseases. The leading clinical trial sponsors are Merck Sharp & Dohme Corp., Cystic Fibrosis Foundation Therapeutics, and [disabled in preview].

Recent Clinical Trials for Denufosol
A Safety and Tolerability Study of Denufosol in 2-4 Year OldsMerck Sharp & Dohme Corp.Phase 2
Study 08-114 Open-label Extension of Study 08-110 - A Multi-Center Study of Denufosol Tetrasodium Inhalation Solution in Patients With Cystic Fibrosis Lung Disease (P08642)Merck Sharp & Dohme Corp.Phase 3
Study of Denufosol Tetrasodium Inhalation Solution in Patients With Cystic Fibrosis (CF) Lung DiseaseMerck Sharp & Dohme Corp.Phase 3

See all Denufosol clinical trials

Clinical Trial Summary for Denufosol

Top disease conditions for Denufosol
Top clinical trial sponsors for Denufosol

See all Denufosol clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.